Related Experiment Video
Updated: Jul 13, 2026
09:02
Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model
Published on: September 27, 2024
ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology
I Klejbor1, E K Stachowiak, D J Bharali
1Institute of Lasers, Photonics and Biophotonics, Department of Chemistry, 458 NSC, State University of New York, Buffalo, NY 14260, USA.
Journal of Neuroscience Methods
|July 28, 2007
Summary
Nanoparticles effectively modeled Huntington
Area of Science:
- Neuroscience
- Biotechnology
- Genetics
Background:
- Expanded polyglutamine (polyQ) proteins are implicated in Huntington's disease (HD) and other neurodegenerative disorders.
- Developing accurate models for studying these conditions is crucial for therapeutic development.
Purpose of the Study:
- To investigate the use of organically modified silica (ORMOSIL) nanoparticles as a non-viral gene delivery system.
- To model brain pathologies associated with expanded polyQ peptides in vivo.
Main Methods:
- ORMOSIL nanoparticles were complexed with plasmids encoding polyQ peptides (Q20 or Q127).
- These complexes were injected into the brains of mice and rats.
- Neuroinflammation markers (GFAP, ED1) and behavioral changes were assessed.
Main Results:
- Q127 expression induced characteristic polyQ aggregates and neuronal pathology in mice and rats.
- Increased reactive astrocytes (GFAP+) and microglia (ED1+) were observed, indicating neuroinflammation.
- Mice exhibited motor impairments, and rats showed enlarged ventricles.
Conclusions:
- Restricted expression of toxic polyQ peptides in the adult brain is sufficient to cause neuropathologies.
- ORMOSIL nanoparticles provide an effective tool for modeling polyQ disorders in vivo.
- This nanotechnology approach can aid in testing gene therapies for genetic brain diseases.
